Laboratory Corp. of America (TICKER: LH) Benchmark And Performance Data

there are 12 of samples in the benchmark for Laboratory Corp. of America in year 2022 in 2022. The total inventory for Laboratory Corp. of America was $423,200,000.00 in 2020. The total inventory for Laboratory Corp. of America was $401,400,000.00 in 2021. The total inventory for Laboratory Corp. of America was $244,700,000.00 in 2019. The total inventory for Laboratory Corp. of America was $237,300,000.00 in 2018. The total inventory for Laboratory Corp. of America was $227,200,000.00 in 2017. The total inventory for Laboratory Corp. of America was $205,200,000.00 in 2016. The total inventory for Laboratory Corp. of America was $191,000,000.00 in 2015. The total inventory for Laboratory Corp. of America was $139,500,000.00 in 2014. The total inventory for Laboratory Corp. of America was $136,500,000.00 in 2013. The total inventory for Laboratory Corp. of America was $121,000,000.00 in 2012. The sales, general, and administrative (SGA) for Laboratory Corp. of America was $1,952,100,000.00 in 2021. The sales, general, and administrative (SGA) for Laboratory Corp. of America was $1,729,300,000.00 in 2020. The sales, general, and administrative (SGA) for Laboratory Corp. of America was $1,628,100,000.00 in 2015. The sales, general, and administrative (SGA) for Laboratory Corp. of America was $1,624,500,000.00 in 2019. The sales, general, and administrative (SGA) for Laboratory Corp. of America was $1,570,900,000.00 in 2018. The sales, general, and administrative (SGA) for Laboratory Corp. of America was $1,499,200,000.00 in 2017. The sales, general, and administrative (SGA) for Laboratory Corp. of America was $1,345,500,000.00 in 2016. The sales, general, and administrative (SGA) for Laboratory Corp. of America was $1,204,300,000.00 in 2014. The sales, general, and administrative (SGA) for Laboratory Corp. of America was $1,128,800,000.00 in 2013. The sales, general, and administrative (SGA) for Laboratory Corp. of America was $1,114,600,000.00 in 2012. The sales, general, and administrative (SGA) for Laboratory Corp. of America was $$1,997,000,000 in 2022. The revenue volatility for Laboratory Corp. of America was 13.76% in 2022. The market capitalization for Laboratory Corp. of America was $29,252,951,000.00 in 2014. The market capitalization for Laboratory Corp. of America was $26,961,952,000.00 in 2013. The market capitalization for Laboratory Corp. of America was $26,674,695,000.00 in 2012. The market capitalization for Laboratory Corp. of America was $24,494,014,000.00 in 2015. The market capitalization for Laboratory Corp. of America was $21,405,971,000.00 in 2020. The market capitalization for Laboratory Corp. of America was $21,326,760,000.00 in 2016. The market capitalization for Laboratory Corp. of America was $20,863,528,000.00 in 2018. The market capitalization for Laboratory Corp. of America was $20,326,612,000.00 in 2019. The market capitalization for Laboratory Corp. of America was $18,350,976,000.00 in 2017. The market capitalization for Laboratory Corp. of America was $17,813,030,000.00 in 2021. The market capitalization for Laboratory Corp. of America was $$18,962,000,000 in 2022. The gross revenue for Laboratory Corp. of America was $9,552,900,000.00 in 2016. The gross revenue for Laboratory Corp. of America was $8,680,100,000.00 in 2015. The gross revenue for Laboratory Corp. of America was $6,011,600,000.00 in 2014. The gross revenue for Laboratory Corp. of America was $5,808,300,000.00 in 2013. The gross revenue for Laboratory Corp. of America was $5,671,400,000.00 in 2012. The gross revenue for Laboratory Corp. of America was $16,120,900,000.00 in 2021. The gross revenue for Laboratory Corp. of America was $13,978,500,000.00 in 2020. The gross revenue for Laboratory Corp. of America was $11,554,800,000.00 in 2019. The gross revenue for Laboratory Corp. of America was $11,333,400,000.00 in 2018. The gross revenue for Laboratory Corp. of America was $10,308,000,000.00 in 2017. The gross revenue for Laboratory Corp. of America was $$14,877,000,000 in 2022. The gross margin for Laboratory Corp. of America was $14.31% in 2022. The days sales outstanding for Laboratory Corp. of America was 55 days in 2022. The days payable outstanding for Laboratory Corp. of America was 27 days in 2022. The days of inventory for Laboratory Corp. of America was $15 in 2022. The cost of goods sold (COGS) for Laboratory Corp. of America was 70.52% in 2022. The cost of goods sold (COGS) for Laboratory Corp. of America was $9,025,700,000.00 in 2020. The cost of goods sold (COGS) for Laboratory Corp. of America was $8,302,300,000.00 in 2019. The cost of goods sold (COGS) for Laboratory Corp. of America was $8,157,000,000.00 in 2018. The cost of goods sold (COGS) for Laboratory Corp. of America was $7,216,200,000.00 in 2017. The cost of goods sold (COGS) for Laboratory Corp. of America was $6,698,900,000.00 in 2016. The cost of goods sold (COGS) for Laboratory Corp. of America was $5,776,800,000.00 in 2015. The cost of goods sold (COGS) for Laboratory Corp. of America was $3,808,500,000.00 in 2014. The cost of goods sold (COGS) for Laboratory Corp. of America was $3,585,100,000.00 in 2013. The cost of goods sold (COGS) for Laboratory Corp. of America was $3,421,700,000.00 in 2012. The cost of goods sold (COGS) for Laboratory Corp. of America was $10,496,600,000.00 in 2021. The cost of goods sold (COGS) for Laboratory Corp. of America was $$10,492,000,000 in 2022. The cash to cash cycle time for Laboratory Corp. of America was 43 in 2022. The annual percentage growth rate of Laboratory Corp. of America was 0.08% in 2022. Laboratory Corp. of America in its benchmark peer group, had rank 6 days for days sales outstanding in 2022. Laboratory Corp. of America in its benchmark peer group, had rank 3 for sales growth in 2022. Laboratory Corp. of America in its benchmark peer group, had rank 3 for gross revenue in 2022. Laboratory Corp. of America in its benchmark peer group, had rank 3 for cash to cash cycle time in 2022. Laboratory Corp. of America in its benchmark peer group, had rank 3 days for days of inventory in 2022. Laboratory Corp. of America in its benchmark peer group, had rank 12 for cost of goods sold as a percent of revenue in 2022. Laboratory Corp. of America headquarters region is South. Laboratory Corp. of America has ticker symbol LH. Laboratory Corp. of America has the following profile: Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics and Labcorp Drug Development. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests.. Laboratory Corp. of America has primary indstury Diagnostics & Research. Laboratory Corp. of America had a $$14,935,000,000 gap between actual performance and next performance rank for gross revenue in competitive benchmarking in 2022. Laboratory Corp. of America had Revvity, Inc., and Danaher, and Thermo Fisher Scientific Inc., and Laboratory Corp. of America, and IQVIA Holdings, and Illumina, and Charles River Laboratories International, and Quest Diagnostics, and Agilent Technologies, and Mettler-Toledo International, and IDEXX Laboratories, and Waters benchmark peer companies for its SIC code in 2022. Laboratory Corp. of America had 80,000 number of employees in 2022. Laboratory Corp. of America had 5.04% gap between actual performance and next performance rank for gross margin in competitive benchmarking in 2022. Laboratory Corp. of America had 5 days gap between actual performance and next performance rank for days sales outstanding in competitive benchmarking in 2022. Laboratory Corp. of America had 4 days gap between actual performance and next performance rank for days of inventory in competitive benchmarking in 2022. Laboratory Corp. of America had 24.88% gap between actual performance and next performance rank for cost of goods sold as a percent of revenue in competitive benchmarking in 2022. Laboratory Corp. of America had 2 days gap between actual performance and next performance rank for cash to cash in competitive benchmarking in 2022. Laboratory Corp. of America had 0.47% gap between actual performance and next performance rank for sales volatility in competitive benchmarking in 2022. Laboratory Corp. of America had 0.01% gap between actual performance and next performance rank for sales growth in competitive benchmarking in 2022. Laboratory Corp. of America can reduce overall cost by $$3,701,000,000 by improving both COGS and SGA to next benchmark tier in 2022. Laboratory Corp. of America can reduce inventory with practices including SKU Reduction in 2022. Laboratory Corp. of America can reduce inventory with practices including Reduce Manufacturing Latency in 2022. Laboratory Corp. of America can reduce inventory with practices including Forecast Accuracy in 2022. Laboratory Corp. of America can reduce inventory with practices including Demand Shaping in 2022. Laboratory Corp. of America can reduce days sales outstanding with practices including in 2022. Laboratory Corp. of America can increase sales revenue by $$14,935,000,000 improving sales performance to next benchmark tier in 2022. Laboratory Corp. of America can increase revenue growth by $$1,000,000 by improving growth performance to next benchmark tier in 2022. Laboratory Corp. of America can increase overall revenue by $$14,936,000,000 by improving both growth and sales performance to next benchmark tier in 2022. Laboratory Corp. of America can increase days payables outstanding with practices including Strategic Sourcing in 2022. Laboratory Corp. of America can increase days payables outstanding by $408,000,000 days by increasing days payables outstanding to next benchmark tier in 2022. Laboratory Corp. of America can improve total financial performance by $$19,387,000,000 by improving revenue, costs, and working capital in 2022. Laboratory Corp. of America can decrease overall working capital by $$750,000,000 by improving inventory, payables and receivables to next benchmark tier in 2022. Laboratory Corp. of America can decrease inventory days by $147,000,000 days by reducing inventory days to next benchmark tier in 2022. Laboratory Corp. of America can decrease days sales outstanding by $196,000,000 days by reducing days sales outstanding to next benchmark tier in 2022. Laboratory Corp. of America can accelerate revenue growth practices including Revenue-optimized Planning in 2022. Laboratory Corp. of America can accelerate revenue growth practices including Pricing Optimization in 2022. Laboratory Corp. of America can accelerate revenue growth practices including Accelerate Design Pipeline in 2022. 96 days was the measured parity or middle performance level for cash to cash cycle time in Laboratory Corp. of America's peer group in 2022. 86 days was the measured parity or middle performance level for days of inventory in Laboratory Corp. of America's peer group in 2022. 57 days was the measured advantage or top third performance level for cash to cash cycle time in Laboratory Corp. of America's peer group in 2022. 55 days was the measured parity or middle performance level for days sales outstanding in Laboratory Corp. of America's peer group in 2022. 50 days was the measured advantage or top third performance level for days sales outstanding in Laboratory Corp. of America's peer group in 2022. 46 days was the measured advantage or top third performance level for days of inventory in Laboratory Corp. of America's peer group in 2022. 45.64% was the measured parity or middle performance level for cost of goods sold as a percent of revenue in Laboratory Corp. of America's peer group in 2022. 43 days was the measured superior or top ten performance level for days sales outstanding in Laboratory Corp. of America's peer group in 2022. 41 days was the measured superior or top ten performance level for cash to cash cycle time in Laboratory Corp. of America's peer group in 2022. 40.67% was the measured advantage or top third performance level for cost of goods sold as a percent of revenue in Laboratory Corp. of America's peer group in 2022. 39.80% was the measured superior or top ten performance level for cost of goods sold as a percent of revenue in Laboratory Corp. of America's peer group in 2022. 28.62% was the measured superior or top ten performance level for gross margin in Laboratory Corp. of America's peer group in 2022. 13.85% was the measured parity or middle performance level for sales volatility in Laboratory Corp. of America's peer group in 2022. 13.30% was the measured advantage or top third performance level for sales volatility in Laboratory Corp. of America's peer group in 2022. 11.86% was the measured superior or top ten performance level for sales volatility in Laboratory Corp. of America's peer group in 2022. 11 days was the measured superior or top ten performance level for days of inventory in Laboratory Corp. of America's peer group in 2022. 0.08% was the measured superior or top ten performance level for sales growth in Laboratory Corp. of America's peer group in 2022. -0.04% was the measured parity or middle performance level for sales growth in Laboratory Corp. of America's peer group in 2022. -0.00% was the measured advantage or top third performance level for sales growth in Laboratory Corp. of America's peer group in 2022. $25.41% was the measured advantage or top third performance level for gross margin in Laboratory Corp. of America's peer group in 2022. $19.35% was the measured parity or middle performance level for gross margin in Laboratory Corp. of America's peer group in 2022. $$5,708,000,000 was the measured parity or middle performance level for gross revenue in Laboratory Corp. of America's peer group in 2022. $$29,812,000,000 was the measured superior or top ten performance level for gross revenue in Laboratory Corp. of America's peer group in 2022. $$13,052,000,000 was the measured advantage or top third performance level for gross revenue in Laboratory Corp. of America's peer group.